The insulin-specific T cells of nonobese diabetic mice recognize a weak MHC-binding segment in more than one form

Journal of Immunology

Volumn 178, Issue 10, 2007, Pages 6051-6057

  Levisetti, Matteo G ^a   Suri, Anish ^a   Petzold, Shirley J ^a   Unanue, Emil R ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Campus Box 8118 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL POPULATION; DIABETES MELLITUS; IMMUNOGENICITY; LIGAND BINDING; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGISTER; T LYMPHOCYTE;

EID: 34248233148     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.10.6051     Document Type: Article

References (43)

1. Wegmann, D. R., and G. S. Eisenbarth. 2000. It's insulin. J. Autoimmun. 15: 286-291.
2. Jasinski, J. M., and G. S. Eisenbarth. 2005. Insulin as a primary autoantigen for type 1A diabetes. Clin. Dev. Immunol. 12: 181-186.
3. Wegmann, D. R., M. Norbury-Glaser, and D. Daniel. 1994. Insulin-specific T cells are a predominant component of islet infiltrates in prediabetic NOD mice. Eur. J. Immunol. 24: 1853-1857.
4. Wegmann, D. R., R. G. Gill, M. Norbury-Glaser, N. Schloot, and D. Daniel. 1994. Analysis of the spontaneous T cell response to insulin in NOD mice. J. Autoimmun. 7: 833-843.
5. Daniel, D., R. G. Gill, N. Schloot, and D. Wegmann. 1995. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur. J. Immunol. 25: 1056-1062.
6. Daniel, D., and D. R. Wegmann. 1996. Intranasal administration of insulin peptide B:9-23 protects NOD mice from diabetes. Annu. NY Acad. Sci. 778: 371-372.
7. Harrison, L. C., M. Dempsey-Collier, D. R. Kramer, and K. Takahashi. 1996. Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J. Exp. Med. 184: 2167-2174.
8. Cetkovic-Cvrlje, M., I. C. Gerling, A. Muir, M. A. Atkinson, J. F. Elliott, and E. H. Leiter. 1997. Retardation or acceleration of diabetes in NOD/Lt mice mediated by intrathymic administration of candidate β-cell antigens. Diabetes 46: 1975-1982.
9. French, M. B., J. Allison, D. S. Cram, H. E. Thomas, M. Dempsey-Collier, A. Silva, H. M. Georgiou, T. W. Kay, L. C. Harrison, and A. M. Lew. 1997. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes 46: 34-39.
10. Jaeckel, E., M. A. Lipes, and H. von Boehmer. 2004. Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes. Nat. Immunol. 5: 1028-1035.
11. Nakayama, M., N. Abiru, H. Moriyama, N. Babaya, E. Liu, D. Miao, L. Yu, D. R. Wegmann, J. C. Hutton, J. F. Elliott, and G. S. Eisenbarth. 2005. Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice. Nature 435: 220-223.
12. 7 homozygosity, and insulin 2 gene knockout. Diabetes 55: 1978-1984.
13. Zekzer, D., F. S. Wong, L. Wen, M. Altieri, T. Gurlo, H. von Grafenstein, and R. S. Sherwin. 1997. Inhibition of diabetes by an insulin-reactive CD4 T-cell clone in the nonobese diabetic mouse. Diabetes 46: 1124-1132.
14. + regulatory T-cells induced by oral insulin treatment protect from type 1 diabetes by blocking the cytokine secretion and pancreatic infiltration of diabetogenic effector T-cells. Diabetes 48: 1720-1729.
15. Du, W., F. S. Wong, M. O. Li, J. Peng, H. Qi, R. A. Flavell, R. Sherwin, and L. Wen. 2006. TGF-β signaling is required for the function of insulin-reactive T regulatory cells. J. Clin. Invest. 116: 1360-1370.
16. g7 molecule: rapid release of CLIP at an endosomal pH. J. Exp. Med. 189: 1723-1734.
17. g7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder. J. Immunol. 165: 3214-3225.
18. Yu, B., L. Gauthier, D. H. Hausmann, and K. W. Wucherpfennig. 2000. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes. Eur. J. Immunol. 30: 2497-2506.
19. Latek, R. R., A. Suri, S. J. Petzold, C. A. Nelson, O. Kanagawa, E. R. Unanue, and D. H. Fremont. 2000. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 12: 699-710.
20. Abiru, N., D. Wegmann, E. Kawasaki, P. Gottlieb, E. Simone, and G. S. Eisenbarth. 2000. Dual overlapping peptides recognized by insulin peptide B:9-23 T cell receptor AV13S3 T cell clones of the NOD mouse. J. Autoimmun. 14: 231-237.
21. Halbout, P., J. P. Briand, C. Becourt, S. Muller, and C. Boitard. 2002. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J. Immunol. 169: 2436-2443.
22. Lacy, P. E., and M. Kostianovsky. 1967. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 16: 35-39.
23. g7 molecule are unique and determined by the amino acid changes in the P9 pocket. J. Immunol. 168: 1235-1243.
24. g7 molecules show common sequence specificity. J. Clin. Invest. 115: 2268-2276.
25. g7 and autoimmune diabetes. Science 288: 505-511.
26. Lee, K. H., K. W. Wucherpfennig, and D. C. Wiley. 2001. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2: 501-507.
27. Suri, A., J. J. Walters, O. Kanagawa, M. L. Gross, and E. R. Unanue. 2003. Specificity of peptide selection by Ag-presenting cells homozygous or heterozygous for expression of class II MHC molecules: the lack of competition. Proc. Natl. Acad. Sci. USA 100: 5330-5335.
28. g7. Eur. J. Immunol. 32: 2105-2116.
29. Zavala-Ruiz, Z., I. Strug, M. W. Anderson, J. Gorski, and L. J. Stern. 2004. A polymorphic pocket at the P10 position contributes to peptide binding specificity in class II MHC proteins. Chem. Biol. 11: 1395-1402.
30. Carson, R. T., K. M. Vignali, D. L. Woodland, and D. A. Vignali. 1997. T cell receptor recognition of MHC class II-bound peptide flanking residues enhances immunogenicity and results in altered TCR V region usage. Immunity 7: 387-399.
31. k histocompatibility molecules. J. Biol. Chem. 277: 42514-42522.
32. Alleva, D. G., A. Gaur, L. Jin, D. Wegmann, P. A. Gottlieb, A. Pahuja, E. B. Johnson, T. Motheral, A. Putnam, P. D. Crowe, et al. 2002. Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide. Diabetes 51: 2126-2134.
33. Liu, G. Y., and D. C. Wraith. 1995. Affinity for class II MHC determines the extent to which soluble peptides tolerize autoreactive T cells in naive and primed adult mice: implications for autoimmunity. Int. Immunol. 7: 1255-1263.
34. Liu, G. Y., P. J. Fairchild, R. M. Smith, J. R. Prowle, D. Kioussis, and D. C. Wraith. 1995. Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3: 407-415.
35. g7 molecules from nonobese diabetic mice are poor peptide binders. J. Immunol. 156: 450-458.
36. g7-dependent reaction. Proc. Natl. Acad. Sci. USA 95: 1721-1724.
37. Fairchild, P. J., R. Wildgoose, E. Atherton, S. Webb, and D. C. Wraith. 1993. An autoantigenic T cell epitope forms unstable complexes with class II MHC: a novel route for escape from tolerance induction. Int. Immunol. 5: 1151-1158.
38. Seamons, A., J. Sutton, D. Bai, E. Baird, N. Bonn, B. F. Kafsack, J. Shabanowitz, D. F. Hunt, C. Beeson, and J. Goverman. 2003. Competition between two MHC binding registers in a single peptide processed from myelin basic protein influences tolerance and susceptibility to autoimmunity. J. Exp. Med. 197: 1391-1397.
39. Martinez, N. R., P. Augstein, A. K. Moustakas, G. K. Papadopoulos, S. Gregori, L. Adorini, D. C. Jackson, and L. C. Harrison. 2003. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J. Clin. Invest. 111: 1365-1371.
40. McInerney, M. F., J. C. Flynn, P. J. Goldblatt, S. M. Najjar, R. S. Sherwin, and C. A. Janeway, Jr. 1996. High density insulin receptor-positive T lymphocytes from nonobese diabetic mice transfer insulitis and diabetes. J. Immunol. 157: 3716-3726.
41. Maynard, J., K. Petersson, D. H. Wilson, E. J. Adams, S. E. Blondelle, M. J. Boulanger, D. B. Wilson, and K. C. Garcia. 2005. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity. Immunity 22: 81-92.
42. Hahn, M., M. J. Nicholson, J. Pyrdol, and K. W. Wucherpfennig. 2005. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor. Nat. Immunol. 6: 490-496.
43. Li, Y., Y. Huang, J. Lue, J. A. Quandt, R. Martin, and R. A. Mariuzza. 2005. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule. EMBO J. 24: 2968-2979.